NEU neuren pharmaceuticals limited

Importance of the trial results & challenges, page-4

  1. 2,982 Posts.
    lightbulb Created with Sketch. 643
    Excellent post Noda - I was about to make some similar comments, but you have done it far more eloquently.

    I haven't re-visited the phase 2 trial results but I don't recall the point that trofinetide "targets mechanisims underlying the disorder rather than a symptomatic medication".

    If this applies to the whole of the autism spectrum, then ramifications are almost mind-boggling (no pun intended).

    My original reading of these results was that they really didn't tell us much that we didn't already know. I'm delighted that now appears not to be the case, however trading over the next few weeks will likely give a pretty good pointer as to how significant this point might be.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$13.88
Change
-0.140(1.00%)
Mkt cap ! $1.727B
Open High Low Value Volume
$13.90 $14.21 $13.64 $4.590M 329.8K

Buyers (Bids)

No. Vol. Price($)
1 600 $13.85
 

Sellers (Offers)

Price($) Vol. No.
$13.96 2894 1
View Market Depth
Last trade - 16.10pm 08/07/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.